SAVA Cassava Sciences Inc

 

---

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

(Rule 13d-102)

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 20) *

 

Cassava Sciences, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

14817C 107

(CUSIP Number)

 

Eric Schoen – Chief Financial Officer

6801 N Capital of Texas Highway, Building 1

Suite 300, Austin, TX 78731

(512) 501-2450

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

 

---

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☐ Rule 13d-1(c)

 

☒ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 14817C 107

13G

Page 2 of 5

 

 

1.	NAME OF REPORTING PERSONS   Remi Barbier
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)   ☐         (b)   ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION   U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 1,480,289
	6	SHARED VOTING POWER 585,226
	7	SOLE DISPOSITIVE POWER 1,480,289
	8	SHARED DISPOSITIVE POWER 585,226

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,065,515
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.2%
12	TYPE OF REPORTING PERSON (see instructions) IN

 

 

CUSIP No. 14817C 107

13G

Page 3 of 5

 

 

Item 1. (a)         Name of Issuer

 

Cassava Sciences, Inc.

 

Item 1. (b)         Address of Issuer’s Principal Executive Offices

 

6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, TX 78731

 

Item 2. (a)         Name of Person Filing

 

Remi Barbier

 

Item 2. (b)         Address of the Principal Office or, if none, residence

 

6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, TX 78731

 

Item 2. (c)         Citizenship

 

USA

 

Item 2. (d)         Title of Class of Securities

 

Common Stock

 

Item 2. (e)         CUSIP Number

 

14817C 107

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)   ☐  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b)   ☐  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c)   ☐  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d)   ☐  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

(e)   ☐  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f)   ☐  An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g)   ☐  A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

(h)   ☐  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)   ☐  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j)   ☐  A non-U.S. institution in accordance with §240,13d-1(b)(1)(ii)(J);

 

(k)   ☐  Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

CUSIP No. 14817C 107

13G

Page 4 of 5

 

 

Item 4.

Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

	(a)	Amount beneficially owned: 2,065,515
	(b)	Percent of class: 4.2%
	(c)	Number of shares as to which the person has:

	(i)	Sole power to vote or to direct the vote 1,480,289
	(ii)	Shared power to vote or to direct the vote 585,226
	(iii)	Sole power to dispose or to direct the disposition of 1,480,289
	(iv)	Shared power to dispose or to direct the disposition of 585,226

 

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ☒.

 

Instruction. Dissolution of a group requires a response to this item.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Item 8.

Identification and Classification of Members of the Group.

 

Item 9.

Notice of Dissolution of Group.

 

Item 10.

Certification.

(a)         The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

(b)         The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):

 

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

CUSIP No. 14817C 107

13G

Page 5 of 5

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	November 4, 2024
	Date
	/s/ Remi Barbier
	Signature
	Remi Barbier
	Name and Title

 

---